Panagiotis Sarantis

1.8k total citations
75 papers, 1.1k citations indexed

About

Panagiotis Sarantis is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Panagiotis Sarantis has authored 75 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 28 papers in Oncology and 17 papers in Cancer Research. Recurrent topics in Panagiotis Sarantis's work include Histone Deacetylase Inhibitors Research (10 papers), Autophagy in Disease and Therapy (10 papers) and MicroRNA in disease regulation (9 papers). Panagiotis Sarantis is often cited by papers focused on Histone Deacetylase Inhibitors Research (10 papers), Autophagy in Disease and Therapy (10 papers) and MicroRNA in disease regulation (9 papers). Panagiotis Sarantis collaborates with scholars based in Greece, Germany and United States. Panagiotis Sarantis's co-authors include Michalis V. Karamouzis, Evangelos Koustas, Athanasios G. Papavassiliou, Adriana Papadimitropoulou, Stamatios Theocharis, Nikolaos Garmpis, Anna Garmpi, Christos Damaskos, Kalliopi‐Anna Poulia and Dimitriοs Schizas and has published in prestigious journals such as International Journal of Molecular Sciences, Annals of Oncology and Nutrients.

In The Last Decade

Panagiotis Sarantis

67 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Panagiotis Sarantis Greece 19 503 476 247 157 156 75 1.1k
Pingting Zhou China 18 709 1.4× 515 1.1× 385 1.6× 180 1.1× 130 0.8× 36 1.3k
Evangelos Koustas Greece 19 642 1.3× 702 1.5× 348 1.4× 154 1.0× 234 1.5× 53 1.4k
Javier Martínez‐Useros Spain 21 671 1.3× 383 0.8× 336 1.4× 95 0.6× 85 0.5× 55 1.2k
Hong Yan China 21 593 1.2× 317 0.7× 340 1.4× 160 1.0× 119 0.8× 70 1.2k
Sandra Guaita‐Esteruelas Spain 16 775 1.5× 388 0.8× 345 1.4× 130 0.8× 129 0.8× 25 1.2k
Sunbin Ling China 19 790 1.6× 533 1.1× 402 1.6× 167 1.1× 265 1.7× 50 1.4k
Stratigoula Sakellariou Greece 19 480 1.0× 398 0.8× 245 1.0× 286 1.8× 271 1.7× 77 1.3k
Marie‐Claude Beauchamp Canada 18 779 1.5× 386 0.8× 229 0.9× 211 1.3× 124 0.8× 28 1.2k
Valentina Grossi Italy 17 647 1.3× 216 0.5× 221 0.9× 97 0.6× 137 0.9× 49 1.0k
Jinghai Song China 15 540 1.1× 218 0.5× 187 0.8× 121 0.8× 102 0.7× 55 928

Countries citing papers authored by Panagiotis Sarantis

Since Specialization
Citations

This map shows the geographic impact of Panagiotis Sarantis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Panagiotis Sarantis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Panagiotis Sarantis more than expected).

Fields of papers citing papers by Panagiotis Sarantis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Panagiotis Sarantis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Panagiotis Sarantis. The network helps show where Panagiotis Sarantis may publish in the future.

Co-authorship network of co-authors of Panagiotis Sarantis

This figure shows the co-authorship network connecting the top 25 collaborators of Panagiotis Sarantis. A scholar is included among the top collaborators of Panagiotis Sarantis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Panagiotis Sarantis. Panagiotis Sarantis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sarantis, Panagiotis, et al.. (2025). Biomarkers for the Evaluation of Immunotherapy in Patients with Cholangiocarcinoma. Cancers. 17(3). 555–555. 3 indexed citations
2.
Sarantis, Panagiotis, Nikolaos Charalampakis, Evangelos Koustas, et al.. (2024). Progastrin: An Overview of Its Crucial Role in the Tumorigenesis of Gastrointestinal Cancers. Biomedicines. 12(4). 885–885.
3.
Anastasiou, Ioanna A., Panagiotis Sarantis, Eleni Rebelos, et al.. (2024). l‐Securinine Induces ROS‐Dependent Apoptosis on Pancreatic Cancer Cells via the PI3K/AKT/mTOR Signaling Pathway. Journal of Biochemical and Molecular Toxicology. 38(11). e70036–e70036.
4.
Papadakos, Stavros P., Θεόδωρος Ανδρουτσάκος, Alexandros Pergaris, et al.. (2023). Unusual Presentation of an Uncommon Malignancy: A 74-Year-Old Woman with Aggressive Fibromatosis of the Large Intestine Presenting as a Liver Mass and the Therapeutic Management. American Journal of Case Reports. 24. e939862–e939862.
5.
Sarantis, Panagiotis, et al.. (2023). Predictive Biomarkers for Immune-Related Endocrinopathies following Immune Checkpoint Inhibitors Treatment. Cancers. 15(2). 375–375. 18 indexed citations
6.
Giannopoulou, Efstathia, Dimitra Manou, Panagiotis Sarantis, et al.. (2023). Resistance to hormone therapy in breast cancer cells promotes autophagy and EGFR signaling pathway. American Journal of Physiology-Cell Physiology. 325(3). C708–C720. 12 indexed citations
7.
Psilopatis, Iason, Christos Damaskos, Nikolaos Garmpis, et al.. (2023). The Role of Hyperthermic Intraperitoneal Chemotherapy in Uterine Cancer Therapy. International Journal of Molecular Sciences. 24(15). 12353–12353. 7 indexed citations
8.
Anastasiou, Ioanna A., Panagiotis Sarantis, Ioanna Eleftheriadou, et al.. (2023). Effects of Hypericin on Cultured Primary Normal Human Dermal Fibroblasts Under Increased Oxidative Stress. The International Journal of Lower Extremity Wounds. 25(1). 213–226. 5 indexed citations
9.
Psilopatis, Iason, Christos Damaskos, Anna Garmpi, et al.. (2023). FDA-Approved Monoclonal Antibodies for Unresectable Hepatocellular Carcinoma: What Do We Know So Far?. International Journal of Molecular Sciences. 24(3). 2685–2685. 16 indexed citations
10.
Sarantis, Panagiotis, Marianna Tzanoudaki, Ioannis Ntanasis‐Stathopoulos, et al.. (2023). Receptor-Binding-Domain-Specific B Cell Responses Induced by mRNA Immunization against SARS-CoV-2. Vaccines. 11(7). 1148–1148. 2 indexed citations
11.
Nikas, Ilias P., Constantinos Giaginis, Paraskevi Alexandrou, et al.. (2022). EPHA2, EPHA4, and EPHA7 Expression in Triple-Negative Breast Cancer. Diagnostics. 12(2). 366–366. 20 indexed citations
12.
Koustas, Evangelos, Panagiotis Sarantis, Nikolaos Papadopoulos, et al.. (2022). Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer—Current Treatment Options and Future Perspectives. International Journal of Molecular Sciences. 23(12). 6664–6664. 24 indexed citations
13.
Damaskos, Christos, Nikolaos Garmpis, Dimitrios Dimitroulis, et al.. (2022). The Role of SNHG15 in the Pathogenesis of Hepatocellular Carcinoma. Journal of Personalized Medicine. 12(5). 753–753. 4 indexed citations
14.
Sarantis, Panagiotis, et al.. (2022). Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors. International Journal of Molecular Sciences. 23(21). 13612–13612. 7 indexed citations
15.
Masaoutis, Christos, Panagiotis Sarantis, Nikolaos Tsoukalas, et al.. (2021). Ephrin Receptors (Ephs) Expression in Thymic Epithelial Tumors: Prognostic Implications and Future Therapeutic Approaches. Diagnostics. 11(12). 2265–2265. 9 indexed citations
16.
Damaskos, Christos, Nikolaos Garmpis, Anna Garmpi, et al.. (2021). Investigational Drug Treatments for Triple-Negative Breast Cancer. Journal of Personalized Medicine. 11(7). 652–652. 14 indexed citations
17.
Theocharis, Stamatios, Constantinos Giaginis, Paraskevi Alexandrou, et al.. (2021). High Pregnane X Receptor (PXR) Expression Is Correlated with Poor Prognosis in Invasive Breast Carcinoma. Diagnostics. 11(11). 1946–1946. 3 indexed citations
18.
Garmpis, Nikolaos, Christos Damaskos, Anna Garmpi, et al.. (2021). Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities. Journal of Personalized Medicine. 11(3). 223–223. 26 indexed citations
19.
Levidou, Georgia, Panagiotis Sarantis, Evangelos Koustas, et al.. (2021). HuR Protein in Hepatocellular Carcinoma: Implications in Development, Prognosis and Treatment. Biomedicines. 9(2). 119–119. 21 indexed citations
20.
Papakyriakou, Athanasios, et al.. (2014). A Zebrafish In Vivo Phenotypic Assay to Identify 3-Aminothiophene-2-Carboxylic Acid-Based Angiogenesis Inhibitors. Assay and Drug Development Technologies. 12(9-10). 527–535. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pingting Zhou Breakdown of academic impact, for papers by Evangelos Koustas Breakdown of academic impact, for papers by Javier Martínez‐Useros Breakdown of academic impact, for papers by Hong Yan Breakdown of academic impact, for papers by Sandra Guaita‐Esteruelas Breakdown of academic impact, for papers by Sunbin Ling Breakdown of academic impact, for papers by Stratigoula Sakellariou Breakdown of academic impact, for papers by Marie‐Claude Beauchamp Breakdown of academic impact, for papers by Valentina Grossi Breakdown of academic impact, for papers by Jinghai Song
Rankless by CCL
2026